Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JULY 2021 Issue has been successfully launched on 1 July 2021.



Atasi Barman*1, Dr. sushmita Basu2, Dr. K.Kuotsu1

1Department of pharmaceutical technology, Jadavpur University, Kolkata, India.
2Associate consultant critical care, India.


Hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs at least forty-eight hours after hospital admission and the designation of ventilator-associated pneumonia (VAP) is given to those patients that develop pneumonia greater than 4872 hours after endotracheal intubation. HAP extends total hospital length of stay by 30% and seven to nine days on an average. Approximately 1% of hospitalized patients are affected by HAP and this infectious process increases total healthcare costs by more than 1 lakh rupee. The major goals of this study is the management of HAP & VAP according to the evidence based guidelines and emphasize early, appropriate antibiotics in adequate doses, while avoiding excessive antibiotics by deescalation of initial antibiotic therapy. Our study was set up in a 12 bedded territory care hospital situated in Kolkata, West Bengal, India. The total number of patient in ICU 618 from those patients, 12 patients had nosocomial pneumonia all were suffering from HAP but no one were suffering from VAP in a period of nine months. It was found that out of 618 patients 12 patients (1.94%) were suffering from HAP. It can be say that in the age group of 40-80 years they are more prone to grow nosocomial pneumonia rather than other age groups. In my study It was found that form 618 patients 354 (57.28%) male patients and form that 7 (1.97%) were suffering from HAP and 264 (42.72%) were female patients and form that 5 (1.89%) were suffering from HAP there was a clear male preponderance. In my study comorbidities in case of male like HTN were 5, DM were 5, COPD was 1 so total comorbidities were 11 and in case of female HTN were 4, DM were 4, IHD was 1, Asthma was 1, thus total co-morbidities were 10 .

Keywords: HAP, nosocomial pneumonia, co-morbidities.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More